Six additional drugs to be added to commercial PPO 15-day Specialty Drug Limitation Program, starting Aug. 1

Starting Aug. 1, 2018, the following six drugs are being added to the Blue Cross Blue Shield of Michigan commercial PPO 15-Day Specialty Drug Limitation Program:

Bosulif^®
Caprelsa^®
Exjade^®
Erivedge^®
Gilotrif^®
Jadenu^®

Instead of a 30-day supply, we’ll limit all fills to a 15-day supply. This includes first fills and refills. Members will pay half of their copayment for a 15-day supply.

Blue Cross limits the day-supply quantity of a medication that a pharmacy can dispense to:

Help save members money on copayments
Reduce drug waste

We’ll add more drugs to the 15-day program throughout the year. Here’s the full list, including the six new drugs:

Blue Cross commercial PPO 15-day Specialty Drug Limitation Program Full drug list as of Aug. 1, 2018
Afinitor^®	Bosulif^®
Afinitor^® Disperz	Cabometyx^®
Calquence^®	Caprelsa^®
Cometriq^®	Erivedge^®
Exjade^®	Gilotrif^®
Imbruvicia^® capsules	Lenvima^®
Nexavar^®	Nerlynx^®
Tarceva^®	Verzenio™
Votrient™	Zejula™
Zelboraf^®	Zytiga™

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2017 American Medical Association. All rights reserved.